Bacillus Calmette-guérin Vaccination to Prevent COVID-19

Clinical trial NCT04414267 · COMPLETED

Trial details

NCT number: NCT04414267
Sponsor: Hellenic Institute for the Study of Sepsis
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

COVID-19 Virus Diseases Corona Virus Infection Coronary Heart Disease Chronic Obstructive Pulmonary Disease

Start date: 2020-05-26
Primary completion: 2021-04-28
Enrollment: 301

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.